chr16-89919709-C-T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_002386.4(MC1R):​c.451C>T​(p.Arg151Cys) variant causes a missense change. The variant allele was found at a frequency of 0.0749 in 1,606,188 control chromosomes in the GnomAD database, including 5,779 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R151H) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.046 ( 229 hom., cov: 33)
Exomes 𝑓: 0.078 ( 5550 hom. )

Consequence

MC1R
NM_002386.4 missense

Scores

6
5
5

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:1U:1B:8O:3

Conservation

PhyloP100: 4.96

Publications

500 publications found
Variant links:
Genes affected
MC1R (HGNC:6929): (melanocortin 1 receptor) This intronless gene encodes the receptor protein for melanocyte-stimulating hormone (MSH). The encoded protein, a seven pass transmembrane G protein coupled receptor, controls melanogenesis. Two types of melanin exist: red pheomelanin and black eumelanin. Gene mutations that lead to a loss in function are associated with increased pheomelanin production, which leads to lighter skin and hair color. Eumelanin is photoprotective but pheomelanin may contribute to UV-induced skin damage by generating free radicals upon UV radiation. Binding of MSH to its receptor activates the receptor and stimulates eumelanin synthesis. This receptor is a major determining factor in sun sensitivity and is a genetic risk factor for melanoma and non-melanoma skin cancer. Over 30 variant alleles have been identified which correlate with skin and hair color, providing evidence that this gene is an important component in determining normal human pigment variation. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.007609129).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0724 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_002386.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MC1R
NM_002386.4
MANE Select
c.451C>Tp.Arg151Cys
missense
Exon 1 of 1NP_002377.4

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MC1R
ENST00000555147.2
TSL:6 MANE Select
c.451C>Tp.Arg151Cys
missense
Exon 1 of 1ENSP00000451605.1
ENSG00000198211
ENST00000556922.1
TSL:2
c.451C>Tp.Arg151Cys
missense
Exon 1 of 5ENSP00000451560.1
MC1R
ENST00000555427.1
TSL:5
c.451C>Tp.Arg151Cys
missense
Exon 3 of 4ENSP00000451760.1

Frequencies

GnomAD3 genomes
AF:
0.0463
AC:
7044
AN:
152234
Hom.:
229
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0148
Gnomad AMI
AF:
0.0504
Gnomad AMR
AF:
0.0167
Gnomad ASJ
AF:
0.0746
Gnomad EAS
AF:
0.000963
Gnomad SAS
AF:
0.00455
Gnomad FIN
AF:
0.0699
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.0741
Gnomad OTH
AF:
0.0272
GnomAD2 exomes
AF:
0.0442
AC:
10719
AN:
242744
AF XY:
0.0447
show subpopulations
Gnomad AFR exome
AF:
0.0132
Gnomad AMR exome
AF:
0.00937
Gnomad ASJ exome
AF:
0.0656
Gnomad EAS exome
AF:
0.000613
Gnomad FIN exome
AF:
0.0705
Gnomad NFE exome
AF:
0.0718
Gnomad OTH exome
AF:
0.0412
GnomAD4 exome
AF:
0.0779
AC:
113202
AN:
1453836
Hom.:
5550
Cov.:
35
AF XY:
0.0754
AC XY:
54534
AN XY:
723648
show subpopulations
African (AFR)
AF:
0.0111
AC:
371
AN:
33472
American (AMR)
AF:
0.0112
AC:
500
AN:
44708
Ashkenazi Jewish (ASJ)
AF:
0.0677
AC:
1768
AN:
26126
East Asian (EAS)
AF:
0.000705
AC:
28
AN:
39698
South Asian (SAS)
AF:
0.00400
AC:
345
AN:
86242
European-Finnish (FIN)
AF:
0.0665
AC:
3042
AN:
45774
Middle Eastern (MID)
AF:
0.00884
AC:
51
AN:
5768
European-Non Finnish (NFE)
AF:
0.0928
AC:
103222
AN:
1111742
Other (OTH)
AF:
0.0643
AC:
3875
AN:
60306
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.488
Heterozygous variant carriers
0
6668
13336
20003
26671
33339
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
3940
7880
11820
15760
19700
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0462
AC:
7045
AN:
152352
Hom.:
229
Cov.:
33
AF XY:
0.0444
AC XY:
3304
AN XY:
74492
show subpopulations
African (AFR)
AF:
0.0148
AC:
615
AN:
41588
American (AMR)
AF:
0.0167
AC:
256
AN:
15310
Ashkenazi Jewish (ASJ)
AF:
0.0746
AC:
259
AN:
3472
East Asian (EAS)
AF:
0.000965
AC:
5
AN:
5182
South Asian (SAS)
AF:
0.00476
AC:
23
AN:
4832
European-Finnish (FIN)
AF:
0.0699
AC:
743
AN:
10628
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.0741
AC:
5039
AN:
68020
Other (OTH)
AF:
0.0270
AC:
57
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
363
726
1090
1453
1816
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
86
172
258
344
430
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0589
Hom.:
435
Bravo
AF:
0.0434
TwinsUK
AF:
0.0995
AC:
369
ALSPAC
AF:
0.0900
AC:
347
ESP6500AA
AF:
0.0171
AC:
75
ESP6500EA
AF:
0.0762
AC:
655
ExAC
AF:
0.0446
AC:
5409
Asia WGS
AF:
0.00491
AC:
17
AN:
3478

ClinVar

ClinVar submissions as Germline
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
4
not provided (5)
-
-
2
Melanoma, cutaneous malignant, susceptibility to, 5 (2)
-
-
2
not specified (2)
1
-
-
SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 2 (1)
-
-
-
ALBINISM, OCULOCUTANEOUS, TYPE II, MODIFIER OF (1)
-
-
-
Increased analgesia from kappa-opioid receptor agonist, female-specific (1)
-
-
-
Skin/hair/eye pigmentation 2, red hair/fair skin (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.19
BayesDel_addAF
Benign
-0.13
T
BayesDel_noAF
Uncertain
0.11
CADD
Uncertain
25
DANN
Pathogenic
1.0
DEOGEN2
Uncertain
0.52
D
Eigen
Pathogenic
0.78
Eigen_PC
Pathogenic
0.67
FATHMM_MKL
Uncertain
0.94
D
LIST_S2
Benign
0.80
T
MetaRNN
Benign
0.0076
T
MetaSVM
Benign
-0.53
T
MutationAssessor
Pathogenic
3.5
M
PhyloP100
5.0
PROVEAN
Pathogenic
-7.4
D
REVEL
Uncertain
0.31
Sift
Pathogenic
0.0
D
Sift4G
Uncertain
0.013
D
Polyphen
1.0
D
Vest4
0.72
MPC
0.13
ClinPred
0.090
T
GERP RS
4.8
Varity_R
0.76
gMVP
0.46
Mutation Taster
=90/10
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1805007; hg19: chr16-89986117; API